Correlation Between Oracle and Purple Biotech

Can any of the company-specific risk be diversified away by investing in both Oracle and Purple Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oracle and Purple Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oracle and Purple Biotech, you can compare the effects of market volatilities on Oracle and Purple Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oracle with a short position of Purple Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oracle and Purple Biotech.

Diversification Opportunities for Oracle and Purple Biotech

0.37

Correlation Coefficient

Oracle  Purple Biotech

Weak diversification

The 3 months correlation between Oracle and Purple is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Oracle and Purple Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Purple Biotech and Oracle is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oracle are associated (or correlated) with Purple Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Purple Biotech has no effect on the direction of Oracle i.e., Oracle and Purple Biotech go up and down completely randomly.

Pair Corralation between Oracle and Purple Biotech

Given the investment horizon of 90 days Oracle is expected to generate 0.91 times more return on investment than Purple Biotech. However, Oracle is 1.1 times less risky than Purple Biotech. It trades about -0.05 of its potential returns per unit of risk. Purple Biotech is currently generating about -0.19 per unit of risk. If you would invest  16,648  in Oracle on December 29, 2024 and sell it today you would lose (2,070) from holding Oracle or give up 12.43% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	85.25%
Values	Daily Returns

Oracle  vs.  Purple Biotech

Oracle

Risk-Adjusted Performance

Very Weak

Over the last 90 days Oracle has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest abnormal performance, the Stock's fundamental indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Purple Biotech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Purple Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Oracle and Purple Biotech

The main advantage of trading using opposite Oracle and Purple Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oracle position performs unexpectedly, Purple Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will offset losses from the drop in Purple Biotech's long position.

The idea behind Oracle and Purple Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.